Phase 2 trial of ozuriftamab vedotin (BA3021), a conditionally binding ROR2-ADC, in patients with heavily pretreated squamous cell carcinoma of the head and neck. Mechanisms of resistance to anti-PD1 ...
Efficient Large Displacement/Large Rotation Dynamic Simulations Using Nonlinear Dynamic Substructures Utilizing reduced-order dynamic math models (DMM) in linear system-level dynamic analyses is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results